These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9882691)

  • 1. Identification of a new amino acid residue capable of modulating agonist efficacy at the homomeric nicotinic acetylcholine receptor, alpha7.
    Vazquez RW; Oswald RE
    Mol Pharmacol; 1999 Jan; 55(1):1-7. PubMed ID: 9882691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
    Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
    J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single point mutation confers properties of the muscle-type nicotinic acetylcholine receptor to homomeric alpha7 receptors.
    Placzek AN; Grassi F; Papke T; Meyer EM; Papke RL
    Mol Pharmacol; 2004 Jul; 66(1):169-77. PubMed ID: 15213309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of agonist selectivity by mutations of conserved amino acids in the binding site of nicotinic acetylcholine receptors.
    Horenstein NA; McCormack TJ; Stokes C; Ren K; Papke RL
    J Biol Chem; 2007 Feb; 282(8):5899-909. PubMed ID: 17189260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist-induced conformational changes in the extracellular domain of alpha 7 nicotinic acetylcholine receptors.
    Lyford LK; Sproul AD; Eddins D; McLaughlin JT; Rosenberg RL
    Mol Pharmacol; 2003 Sep; 64(3):650-8. PubMed ID: 12920201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical elements determining diversity in agonist binding and desensitization of neuronal nicotinic acetylcholine receptors.
    Corringer PJ; Bertrand S; Bohler S; Edelstein SJ; Changeux JP; Bertrand D
    J Neurosci; 1998 Jan; 18(2):648-57. PubMed ID: 9425007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of channel gating located in the N-terminal extracellular domain of nicotinic alpha7 receptor.
    Anand R; Nelson ME; Gerzanich V; Wells GB; Lindstrom J
    J Pharmacol Exp Ther; 1998 Nov; 287(2):469-79. PubMed ID: 9808669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of receptor activation and agonist selectivity by highly conserved tryptophans in the nicotinic acetylcholine receptor binding site.
    Williams DK; Stokes C; Horenstein NA; Papke RL
    J Pharmacol Exp Ther; 2009 Jul; 330(1):40-53. PubMed ID: 19339660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for Leu118 of loop E in agonist binding to the alpha 7 nicotinic acetylcholine receptor.
    Amiri S; Shimomura M; Vijayan R; Nishiwaki H; Akamatsu M; Matsuda K; Jones AK; Sansom MS; Biggin PC; Sattelle DB
    Mol Pharmacol; 2008 Jun; 73(6):1659-67. PubMed ID: 18339894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N,N-disubstituted piperazines: synthesis and affinities at alpha4beta2(*) and alpha7(*) neuronal nicotinic acetylcholine receptors.
    Chen J; Norrholm S; Dwoskin LP; Crooks PA; Bai D
    Bioorg Med Chem Lett; 2003 Jan; 13(1):97-100. PubMed ID: 12467625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tethered agonist analogs as site-specific probes for domains of the human α7 nicotinic acetylcholine receptor that differentially regulate activation and desensitization.
    Wang J; Horenstein NA; Stokes C; Papke RL
    Mol Pharmacol; 2010 Dec; 78(6):1012-25. PubMed ID: 20823218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling.
    Parikh V; Ji J; Decker MW; Sarter M
    J Neurosci; 2010 Mar; 30(9):3518-30. PubMed ID: 20203212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strychnine activates neuronal alpha7 nicotinic receptors after mutations in the leucine ring and transmitter binding site domains.
    Palma E; Fucile S; Barabino B; Miledi R; Eusebi F
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13421-6. PubMed ID: 10557336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conserved arginine with non-conserved function is a key determinant of agonist selectivity in α7 nicotinic ACh receptors.
    Minguez-Viñas T; Nielsen BE; Shoemark DK; Gotti C; Sessions RB; Mulholland AJ; Bouzat C; Wonnacott S; Gallagher T; Bermudez I; Oliveira AS
    Br J Pharmacol; 2021 Apr; 178(7):1651-1668. PubMed ID: 33506493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain.
    Anderson DJ; Bunnelle W; Surber B; Du J; Surowy C; Tribollet E; Marguerat A; Bertrand D; Gopalakrishnan M
    J Pharmacol Exp Ther; 2008 Jan; 324(1):179-87. PubMed ID: 17959745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of a conserved lysine residue in the N-terminal domain of alpha7 nicotinic receptors affect gating and binding of nicotinic agonists.
    Criado M; Mulet J; Bernal JA; Gerber S; Sala S; Sala F
    Mol Pharmacol; 2005 Dec; 68(6):1669-77. PubMed ID: 16129734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
    Jonnala RR; Buccafusco JJ
    J Neurosci Res; 2001 Nov; 66(4):565-72. PubMed ID: 11746376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal nicotinic threonine-for-leucine 247 alpha7 mutant receptors show different gating kinetics when activated by acetylcholine or by the noncompetitive agonist 5-hydroxytryptamine.
    Palma E; Maggi L; Eusebi F; Miledi R
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9915-9. PubMed ID: 9275226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist and antagonist effects of nicotine on chick neuronal nicotinic receptors are defined by alpha and beta subunits.
    Hussy N; Ballivet M; Bertrand D
    J Neurophysiol; 1994 Sep; 72(3):1317-26. PubMed ID: 7807214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.